Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies Read More > June 1, 2012
Implications for psychedelic-assisted psychotherapy: Functional magnetic resonance imaging study with psilocybin Read More > March 1, 2012
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Read More > January 29, 2012
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers Read More > September 28, 2011
Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness Read More > September 28, 2011
Revisiting Wasson's Soma: Exploring the Effects of Preparation on the Chemistry of Amanita Muscaria Read More > September 20, 2011
Psychedelic Experience as a Heuristic Tool for Exploring the Mind and the Brain Read More > September 11, 2011
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects Read More > June 15, 2011
In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin 2A Receptor Binding in MDMA and Hallucinogen Users Read More > June 6, 2011
